Switch to:

Ophthotech Corp (OPHT) Ownership Data

Short Interest History (%)

This is the historical short interest of Ophthotech Corp, as measured by the Short Percentage Of Float.

Date Short Interest
July 15, 201511.2
June 30, 201510.22
June 15, 201510.39
May 29, 20159.76
May 15, 201510.4
April 30, 20159.6
April 15, 201510.39
March 31, 201516.46
March 13, 201516.8
February 27, 201516.39
February 13, 201515.45
January 30, 201515.15
January 15, 201514.41
December 31, 201413.65
December 15, 201413.23
November 28, 201413.53
November 14, 201417.03
October 31, 201417.47
October 15, 201417.76
September 30, 201417.92
September 15, 201415.74
August 29, 201415.43
August 15, 201415.2
July 31, 201414.68
July 15, 201414.71
June 30, 201412.57
June 13, 201410.85
May 30, 201412.11
May 15, 201416.78
April 30, 201414.87
April 15, 201414.57
March 31, 201421.29
March 14, 201421.4
February 28, 201416.16
February 14, 201415.91
January 31, 201415.58
January 15, 201413.09
December 31, 201316.53
December 13, 201312.65
November 29, 201310.45
November 15, 20138.48
October 31, 20132.37
October 15, 20131.69
September 30, 20131.14

Institutional Ownership History (%)

This the Institutional Ownership History of Ophthotech CorpPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
March 31, 201595
December 31, 201497
September 30, 201492
March 31, 201489
December 31, 201358
September 30, 201346

Insider ownership (%)

This is the historical insider ownership of Ophthotech Corp. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Samir C. Patel, M.D.President259,2920.76%2015-06-19
Dr. Nicholas G. GalakatosDirector14,184less than 0.1%2015-06-12
Mr. Axel BolteDirector2,500less than 0.1%2015-03-30
Dr. Thomas Dyrberg,M.D.,D.M.Sc.Director700less than 0.1%2013-09-30

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value($1000)
Fidelity Management and Research Company   Premium Plus5,126,0722015-03-3114.970.03238,516
Novo A/S   Premium Plus4,910,4872015-03-3114.3419.43228,485
Hbm Bioventures Cayman Ltd3,639,9022014-04-0210.92N/A129,854
JHL Capital Group LLC   Premium Plus3,265,0002015-03-319.5313.98151,920
Fidelity® Select Biotechnology Portfolio3,016,8352015-05-318.800.96150,902
Orbimed Advisors, LLC   Premium Plus1,668,6002015-03-314.870.6677,640
HBM Healthcare Investments Ltd1,597,3662014-09-104.77N/A62,233
Clarus Ventures LLC   Premium Plus1,554,7442015-03-314.5430.0772,342
SVLSF IV LLC1,455,0172015-05-224.24N/A65,883
T. Rowe Price Associates, Inc.   Premium Plus1,400,9662015-03-314.090.0165,187

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK